| Name | Sector | Instrument | Assets |
|---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 11.50% |
Eli Lilly And Co | Healthcare | Forgn. Eq | 6.83% |
Max Healthcare Institute Ltd. | Healthcare | Equity | 5.92% |
Cipla Ltd. | Healthcare | Equity | 5.66% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.18% |
Divi's Laboratories Ltd. | Healthcare | Equity | 5.06% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 4.47% |
Johnson & Johnson Ltd. | Healthcare | Forgn. Eq | 3.93% |
Lupin Ltd. | Healthcare | Equity | 3.42% |
AbbVie Inc | Healthcare | Forgn. Eq | 3.17% |
Fortis Healthcare Ltd. | Healthcare | Equity | 2.95% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 2.88% |
Laurus Labs Ltd. | Healthcare | Equity | 2.37% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 2.10% |
Merck & Co Inc (US) | Healthcare | Forgn. Eq | 2.07% |
Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 1.98% |
Novartis AG | Healthcare | ADS/ADR | 1.96% |
Mankind Pharma Ltd. | Healthcare | Equity | 1.82% |
Alkem Laboratories Ltd. | Healthcare | Equity | 1.78% |
Abbott Laboratories | Healthcare | Forgn. Eq | 1.77% |
Thermo Fisher Scientific Inc. | Healthcare | Forgn. Eq | 1.76% |
Intuitive Surgical Inc. (USA) | Healthcare | Forgn. Eq | 1.62% |
Amgen Inc. (USA) | Healthcare | Forgn. Eq | 1.47% |
Biocon Ltd. | Healthcare | Equity | 1.39% |
Ipca Laboratories Ltd. | Healthcare | Equity | 1.33% |
Novo Nordisk A/S - ADR | Healthcare | ADS/ADR | 1.25% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 1.24% |
Gilead Sciences Inc. (USA) | Healthcare | Forgn. Eq | 1.23% |
Danaher Corporation | Healthcare | Forgn. Eq | 1.15% |
Medtronic | Healthcare | Forgn. Eq | 1.07% |
Stryker Corp | Healthcare | Forgn. Eq | 1.01% |
Narayana Hrudayalaya Ltd. | Healthcare | Equity | 0.91% |
Vertex Pharmaceuticals Inc. (USA) | Healthcare | Forgn. Eq | 0.88% |
Gland Pharma Ltd. | Healthcare | Equity | 0.85% |
Syngene International Ltd. | Healthcare | Equity | 0.77% |
Ajanta Pharma Ltd. | Healthcare | Equity | 0.73% |
Piramal Pharma Ltd. | Healthcare | Equity | 0.73% |
Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 0.71% |
Global Health Ltd. | Healthcare | Equity | 0.66% |
Regeneron Pharmaceuticals Inc | Healthcare | Forgn. Eq | 0.64% |
Becton Dickinson And Co | Healthcare | Forgn. Eq | 0.44% |
Cohance Lifesciences Ltd. | Healthcare | Equity | 0.42% |
Agilent Technologies Inc | Healthcare | Forgn. Eq | 0.34% |
Iqvia Holdings | Healthcare | Forgn. Eq | 0.31% |
Illumina Inc. (USA) | Healthcare | Forgn. Eq | 0.16% |
| Min. for 1st investment | Not Supported |
| Min. for 2nd investment onwards | Not Supported |
| Min. for SIP | Not Supported |
| 1Y | 3Y | 5Y | All | |
|---|---|---|---|---|
| Fund returns | 6.8% | 18.4% | 14.0% | 15.4% |
| Category average | 0.5% | 21.9% | 15.6% | NA |
| Rank with in category | 1 | 16 | 9 | NA |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
If you redeem within one year, returns are taxed at 20%. If you redeem after one year, returns exceeding Rs 1.25 lakh in a financial year are taxed at 12.5%.